Professional Documents
Culture Documents
Primary erythromelalgia may develop at any age. Secondary erythromelalgia occurs most often
in those over 40 years of age.
Lower extremities such as the soles of feet and toes are most involved. Upper extremity
involvement includes the fingers and hands. It may affect one side of the body (unilateral),
particularly in secondary cases.
Less frequently, symptoms may also appear in the face, ears, and other parts of the body.
The classic description of erythromelalgia is red, painful, warm hands or feet, brought on by
warming or hanging the limb downward, and relieved with cooling and elevation.
Some patients notice a continual burning, while others are troubled by intermittent
flare-ups.
Flare-ups may last minutes to days and typically occur late in the day and continue
through the night.
Usually attacks begin with an itching sensation, progressing to a more severe pain with a
burning sensation.
During an attack the affected extremity becomes warm, tender, swollen, and appears
dusky red and sometimes mottled.
Pain may be so intense that the patient cannot walk.
Diagnosis of Erythromelalgia
Diagnosis is based fairly much on the clinical picture, hence is often difficult because of the
intermittent nature of the disease.
If in doubt, a trial of immersing an affected area in hot water for 10–30 minutes may sometimes
provoke an attack and support the diagnosis.
Treatment of erythromelalgia (Dermnet)
- The underlying cause must be treated where possible in secondary erythromelalgia.
- Cooling
- Topical therapy: Capsaicin cream (varying results) , Amitriptyline-ketamine compound
- Oral medications:
Aspirin: in case of thrombocytosis or polycythaemia vera
Na channel blockers: Mexiletine
Ca antagonists: nifedipine, diltiazem
Prostaglandins: misoprostol
IV infusions: Nitroprusside, lignocaine, prostaglandin
Medications for neuropathic pain:
SNRI
TCA
Gabapentinoids
Carbamazepine
Antihistamines: Cyproheptadine, pizotifen- non sedating antihistamine cetirizine
did not show improvement
- Novel Nav1.7 Agents
- Surgical interventions: sympathectomy (thoracic for hands and lumbar for feet)
- Injection of Botulinum toxin type A =>by blocking the release of substance P and glutamate